PREMALIGNANT LESION
Clinical trials for PREMALIGNANT LESION explained in plain language.
Never miss a new study
Get alerted when new PREMALIGNANT LESION trials appear
Sign up with your email to follow new studies for PREMALIGNANT LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a shot stop mouth cancer before it starts?
Disease control Recruiting nowThis study tests if injecting the cancer drug nivolumab directly into high-risk precancerous mouth lesions can stop them from turning into cancer. About 45 adults with these lesions will receive either the drug or a placebo injection. The goal is to see if the treatment is safe a…
Matched conditions: PREMALIGNANT LESION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
Diagnosis Recruiting nowThis study tests whether artificial intelligence (AI) can help doctors better detect H. pylori infection and precancerous stomach changes during routine endoscopy. The goal is to see if AI assistance can reduce deaths from stomach cancer. The trial will enroll 6,000 adults aged 2…
Matched conditions: PREMALIGNANT LESION
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC